Literature DB >> 29559380

Circulating tumor cell isolation, culture, and downstream molecular analysis.

Sandhya Sharma1, Rachel Zhuang2, Marisa Long2, Mirjana Pavlovic3, Yunqing Kang4, Azhar Ilyas5, Waseem Asghar6.   

Abstract

Circulating tumor cells (CTCs) are a major contributor of cancer metastases and hold a promising prognostic significance in cancer detection. Performing functional and molecular characterization of CTCs provides an in-depth knowledge about this lethal disease. Researchers are making efforts to design devices and develop assays for enumeration of CTCs with a high capture and detection efficiency from whole blood of cancer patients. The existing and on-going research on CTC isolation methods has revealed cell characteristics which are helpful in cancer monitoring and designing of targeted cancer treatments. In this review paper, a brief summary of existing CTC isolation methods is presented. We also discuss methods of detaching CTC from functionalized surfaces (functional assays/devices) and their further use for ex-vivo culturing that aid in studies regarding molecular properties that encourage metastatic seeding. In the clinical applications section, we discuss a number of cases that CTCs can play a key role for monitoring metastases, drug treatment response, and heterogeneity profiling regarding biomarkers and gene expression studies that bring treatment design further towards personalized medicine.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell enrichment; Circulating tumor cells (CTCs); Liquid biopsy; Personalized therapies; Point of care

Mesh:

Year:  2018        PMID: 29559380      PMCID: PMC5971144          DOI: 10.1016/j.biotechadv.2018.03.007

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  189 in total

1.  Pulsed plasma polymerization for controlling shrinkage and surface composition of nanopores.

Authors:  Waseem Asghar; Azhar Ilyas; Rajendra R Deshmukh; Sulak Sumitsawan; Richard B Timmons; Samir M Iqbal
Journal:  Nanotechnology       Date:  2011-06-02       Impact factor: 3.874

2.  Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction.

Authors:  J E Hardingham; D Kotasek; B Farmer; R N Butler; J X Mi; R E Sage; A Dobrovic
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

Review 3.  Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes.

Authors:  Lori M Millner; Mark W Linder; Roland Valdes
Journal:  Ann Clin Lab Sci       Date:  2013       Impact factor: 1.256

4.  Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma.

Authors:  Philip C Gach; Peter J Attayek; Rebecca L Whittlesey; Jen Jen Yeh; Nancy L Allbritton
Journal:  Biosens Bioelectron       Date:  2013-11-18       Impact factor: 10.618

5.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

6.  Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Authors:  James L Mohler; Andrew J Armstrong; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas Farrington; Celestia S Higano; Eric Mark Horwitz; Philip W Kantoff; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R MacVicar; Arnold W Malcolm; David Miller; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Stan Rosenfeld; Sandy Srinivas; Seth A Strope; Jonathan Tward; Przemyslaw Twardowski; Patrick C Walsh; Maria Ho; Dorothy A Shead
Journal:  J Natl Compr Canc Netw       Date:  2012-09       Impact factor: 11.908

7.  A microfluidic device for label-free, physical capture of circulating tumor cell clusters.

Authors:  A Fatih Sarioglu; Nicola Aceto; Nikola Kojic; Maria C Donaldson; Mahnaz Zeinali; Bashar Hamza; Amanda Engstrom; Huili Zhu; Tilak K Sundaresan; David T Miyamoto; Xi Luo; Aditya Bardia; Ben S Wittner; Sridhar Ramaswamy; Toshi Shioda; David T Ting; Shannon L Stott; Ravi Kapur; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner
Journal:  Nat Methods       Date:  2015-05-18       Impact factor: 28.547

8.  Detection and cultivation of circulating tumor cells in gastric cancer.

Authors:  Katarina Kolostova; Rafal Matkowski; Robert Gürlich; Krzysztof Grabowski; Katarzyna Soter; Robert Lischke; Jan Schützner; Vladimir Bobek
Journal:  Cytotechnology       Date:  2015-04-11       Impact factor: 2.058

9.  Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors:  Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

10.  Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.

Authors:  D J E Peeters; B De Laere; G G Van den Eynden; S J Van Laere; F Rothé; M Ignatiadis; A M Sieuwerts; D Lambrechts; A Rutten; P A van Dam; P Pauwels; M Peeters; P B Vermeulen; L Y Dirix
Journal:  Br J Cancer       Date:  2013-03-07       Impact factor: 7.640

View more
  37 in total

Review 1.  Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.

Authors:  Xiaofen Zhang; Shaoqing Ju; Xudong Wang; Hui Cong
Journal:  Clin Exp Med       Date:  2019-06-12       Impact factor: 3.984

2.  Integrated microdevice with a windmill-like hole array for the clog-free, efficient, and self-mixing enrichment of circulating tumor cells.

Authors:  Hao Li; Jinze Li; Zhiqi Zhang; Zhen Guo; Changsong Zhang; Zixu Wang; Qiuquan Guo; Chao Li; Chuanyu Li; Jia Yao; Anran Zheng; Jingyi Xu; Qingxue Gao; Wei Zhang; Lianqun Zhou
Journal:  Microsyst Nanoeng       Date:  2022-02-15       Impact factor: 7.127

Review 3.  Molecular Profiling of Liquid Biopsies for Precision Oncology.

Authors:  Edgar E Gonzalez-Kozlova
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved.

Authors:  Yutaka Shimada; Tetsuo Sudo; Shusuke Akamatsu; Takuro Sunada; Akira Myomoto; Kiyoshi Okano; Kazuharu Shimizu
Journal:  J Pers Med       Date:  2022-04-21

Review 5.  Exosomal biomarkers for cancer diagnosis and patient monitoring.

Authors:  Amy Makler; Waseem Asghar
Journal:  Expert Rev Mol Diagn       Date:  2020-02-20       Impact factor: 5.225

6.  Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Authors:  Mio Ikeda; Yasuhiro Koh; Shunsuke Teraoka; Koichi Sato; Jun Oyanagi; Atsushi Hayata; Nahomi Tokudome; Hiroaki Akamatsu; Yuichi Ozawa; Katsuya Endo; Masayuki Higuchi; Masanori Nakanishi; Hiroki Ueda; Nobuyuki Yamamoto
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

7.  Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications.

Authors:  Nuria Carmona-Ule; Miriam González-Conde; Carmen Abuín; Juan F Cueva; Patricia Palacios; Rafael López-López; Clotilde Costa; Ana Belén Dávila-Ibáñez
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

Review 8.  Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines.

Authors:  Sushant Prajapati; Taylor Hinchliffe; Vinay Roy; Nimit Shah; Caroline N Jones; Girgis Obaid
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.525

9.  Deregulation of protein phosphatase 2A inhibitor SET is associated with malignant progression in breast cancer.

Authors:  Katsunori Tozuka; Pattama Wongsirisin; Shigenori E Nagai; Yasuhito Kobayashi; Miki Kanno; Kazuyuki Kubo; Ken Takai; Kenichi Inoue; Hiroshi Matsumoto; Yoshihito Shimizu; Masami Suganuma
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

10.  Combination of CT and telomerase+ circulating tumor cells improves diagnosis of small pulmonary nodules.

Authors:  Wen Zhang; Xinchun Duan; Zhenrong Zhang; Zhenrong Yang; Changyun Zhao; Chunzi Liang; Zhidong Liu; Shujun Cheng; Kaitai Zhang
Journal:  JCI Insight       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.